Friday June 14, 2019 Change 5.41% Price $0.06
Chart period: 2019-03-15 - 2019-06-14
VOLUME
Sell
TREND
Sell
MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Will ANTH stock price go up or down on Mon, 17 Jun 2019?

Predict

Anthera Pharmaceuticals Forecast and Stock Analysis

Technical ANTH stock analysis for Friday June 14, 2019.

Hold candidate since 2019-06-14


Anthera Pharmaceuticals gained 5.41% in the last trading day ( Friday, 14th Jun 2019 ), rising from $0.06 to $0.06 During day the stock fluctuated 24.08% from a day low at $0.05 to a day high of $0.06. The price has been going up and down for this period, and there has been a 7.32% gain for the last 2 weeks. Volume fell in the last day by -7 867 shares, and in total, 10 811 shares bought and sold for approximately $678.07. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the ANTH stock price was $0.09 and low was $0.05.
  • 90 day high was $0.10 and low was $0.05.
  • 52 week high for the Anthera Pharmaceuticals - $0.33 and low - $0.01.

Trend

Anthera Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -36.38% during the next 3 months and, with 90% probability hold a price between $0.03 and $0.05 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Thursday June 13, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Anthera Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.07. On a fall, the stock will find some support from the short-term average at $0.06. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 42 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Anthera Pharmaceuticals finds support from accumulated volume at $0.06.

Support: $0.06 Price: $0.06 Resistance: $0.06

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.01 between high and low, or 24.08%. For the last week the stock has had a daily average volatility of 22.69%.

Our recommended stoploss: $0.06 (-5.01%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

22.69 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Anthera Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Hold/Accumulate Upgraded

Will ANTH stock price go up or down on Mon, 17 Jun 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank